Double maintains 1 strategies that include FATE - Fate Therapeutics, Inc.
Current Value
$1.171 Year Return
Current Value
$1.171 Year Return
Yahoo
SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on July 2, 2025 the Company granted (i) non-qualified stock options to one newly-hired non-executive employee to purchase a total of 30,000 shares of the Company’s common stock at a
Finnhub
Fate Therapeutics, Inc. added to Russell 3000E Index...
Finnhub
Fate Therapeutics, Inc. added to Russell Microcap Index...
Finnhub
Fate Therapeutics, Inc. added to Russell Microcap Value Index...
Finnhub
Fate Therapeutics, Inc. added to Russell 3000E Value Index...
Yahoo
Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NOC | -14.69% | $73.96B | +18.95% | 1.66% |
CBOE | -13.14% | $24.55B | +38.09% | 1.08% |
CME | -13.02% | $99.17B | +44.04% | 1.75% |
K | -13.01% | $27.64B | +40.17% | 2.86% |
KMB | -12.20% | $43.78B | -6.43% | 3.77% |
BULL | -12.05% | $6.21B | +14.78% | 0.00% |
HUSA | -10.22% | $20.99M | -8.33% | 0.00% |
ACI | -9.70% | $12.57B | +13.79% | 2.42% |
EQNR | -9.69% | $72.95B | +3.47% | 5.32% |
KR | -9.39% | $46.75B | +34.05% | 1.81% |
CTRE | -9.30% | $5.87B | +17.71% | 4.08% |
TEF | -8.68% | $29.35B | +18.72% | 6.32% |
INGR | -8.60% | $8.77B | +18.80% | 2.35% |
ENIC | -7.98% | $4.86B | +24.70% | 0.21% |
CQP | -7.29% | $26.50B | +6.79% | 5.69% |
CHD | -6.95% | $24.40B | -4.48% | 1.17% |
ED | -6.91% | $36.42B | +10.51% | 3.36% |
LITB | -6.79% | $24.26M | -71.62% | 0.00% |
TW | -6.59% | $28.74B | +28.27% | 0.33% |
PGR | -6.51% | $146.19B | +17.73% | 1.98% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRBU | 55.53% | $161.83M | -7.45% | 0.00% |
CRSP | 55.38% | $5.10B | +3.85% | 0.00% |
RXRX | 55.09% | $2.47B | -25.59% | 0.00% |
ALLO | 55.03% | $275.60M | -52.99% | 0.00% |
NTLA | 53.69% | $1.26B | -50.63% | 0.00% |
BEAM | 50.85% | $2.22B | -14.88% | 0.00% |
IMNM | 48.07% | $778.76M | -31.05% | 0.00% |
YMAB | 47.59% | $204.74M | -62.55% | 0.00% |
RGNX | 47.08% | $456.52M | -28.72% | 0.00% |
CGEM | 46.55% | $462.68M | -51.55% | 0.00% |
IGMS | 46.49% | $81.76M | -85.38% | 0.00% |
MGNX | 46.39% | $99.68M | -66.02% | 0.00% |
ZNTL | 45.71% | $98.57M | -65.58% | 0.00% |
ABCL | 45.45% | $1.27B | +35.78% | 0.00% |
IDYA | 44.91% | $2.00B | -42.45% | 0.00% |
ARWR | 44.66% | $2.60B | -33.24% | 0.00% |
GBIO | 44.64% | $25.00M | -86.68% | 0.00% |
KURA | 43.43% | $550.62M | -71.03% | 0.00% |
EDIT | 42.71% | $256.16M | -44.06% | 0.00% |
DNLI | 42.17% | $2.23B | -33.52% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 53.43% | $1.03B | 0.75% |
GNOM | 51.99% | $46.47M | 0.5% |
XBI | 46.80% | $4.81B | 0.35% |
IWC | 43.67% | $840.86M | 0.6% |
PTH | 39.41% | $96.25M | 0.6% |
IBB | 38.80% | $5.37B | 0.45% |
IWM | 37.62% | $65.64B | 0.19% |
VTWO | 37.42% | $12.65B | 0.07% |
PINK | 37.37% | $130.30M | 0.5% |
IWN | 37.19% | $11.34B | 0.24% |
IWO | 36.75% | $11.77B | 0.24% |
ARKK | 36.53% | $6.81B | 0.75% |
GSSC | 36.20% | $591.16M | 0.2% |
CPRJ | 35.88% | $52.43M | 0.69% |
PBE | 35.81% | $226.91M | 0.58% |
KJUL | 35.14% | $159.39M | 0.79% |
RDTE | 34.75% | $139.04M | 0.97% |
SCHA | 34.41% | $17.61B | 0.04% |
IWMY | 34.38% | $120.43M | 1.02% |
PRFZ | 34.37% | $2.41B | 0.34% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -33.76% | $315.93M | 1.43% |
VIXY | -23.49% | $184.73M | 0.85% |
DFNM | -15.91% | $1.58B | 0.17% |
SHYD | -15.75% | $331.91M | 0.35% |
BSMR | -14.52% | $258.51M | 0.18% |
VRIG | -14.40% | $1.21B | 0.3% |
TAIL | -13.90% | $94.86M | 0.59% |
MLN | -13.52% | $513.19M | 0.24% |
CTA | -13.33% | $1.08B | 0.76% |
FMHI | -12.89% | $746.85M | 0.7% |
BSMW | -12.79% | $107.49M | 0.18% |
PZA | -12.69% | $2.83B | 0.28% |
PWZ | -12.67% | $776.05M | 0.28% |
AGZD | -12.17% | $98.56M | 0.23% |
SMB | -12.08% | $276.62M | 0.07% |
TAXF | -11.94% | $477.91M | 0.29% |
STPZ | -11.51% | $443.27M | 0.2% |
ITM | -11.40% | $1.87B | 0.18% |
VTIP | -11.31% | $15.15B | 0.03% |
CMF | -10.59% | $3.50B | 0.08% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SCHQ | -<0.01% | $779.81M | 0.03% |
VGLT | 0.01% | $9.59B | 0.04% |
BBAG | -0.02% | $1.26B | 0.03% |
BAB | -0.05% | $924.53M | 0.28% |
MINT | -0.11% | $13.32B | 0.35% |
KMLM | 0.12% | $187.82M | 0.9% |
SCHZ | -0.14% | $8.54B | 0.03% |
MINO | -0.15% | $318.78M | 0.39% |
FLRT | 0.16% | $525.35M | 0.6% |
IBTG | -0.18% | $1.92B | 0.07% |
BIV | -0.19% | $23.15B | 0.03% |
FXE | 0.21% | $588.06M | 0.4% |
JBND | -0.24% | $2.35B | 0.25% |
VUSB | -0.28% | $5.37B | 0.1% |
KBA | 0.28% | $177.74M | 0.56% |
SGOV | 0.28% | $50.93B | 0.09% |
AGG | 0.29% | $128.01B | 0.03% |
IBDR | 0.31% | $3.34B | 0.1% |
IBDW | -0.31% | $1.57B | 0.1% |
ASHR | -0.34% | $1.93B | 0.65% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RSG | 0.05% | $75.03B | +20.83% | 0.97% |
TALO | 0.07% | $1.61B | -23.80% | 0.00% |
FINV | 0.11% | $1.44B | +105.38% | 2.68% |
IMNN | 0.13% | $13.21M | -54.55% | 0.00% |
HIHO | -0.16% | $7.55M | -21.86% | 4.27% |
CCI | 0.17% | $45.27B | +1.59% | 5.56% |
EXE | -0.17% | $25.04B | +26.02% | 2.18% |
XEL | 0.18% | $39.48B | +26.57% | 3.29% |
THC | -0.20% | $16.13B | +29.86% | 0.00% |
AMSF | -0.21% | $822.59M | +1.65% | 3.52% |
MKC | -0.21% | $19.44B | +1.76% | 2.45% |
SAR | -0.23% | - | - | 13.10% |
BG | 0.24% | $10.29B | -30.73% | 3.59% |
TXO | 0.27% | $825.05M | -29.00% | 15.77% |
RRC | -0.28% | $9.00B | +10.47% | 0.89% |
NMFC | -0.30% | - | - | 12.20% |
SRRK | 0.31% | $3.62B | +326.82% | 0.00% |
GFL | 0.31% | $17.36B | +24.70% | 0.12% |
KVUE | -0.31% | $40.16B | +16.74% | 3.94% |
SBS | -0.32% | $13.75B | +30.48% | 3.28% |